Skip to main content
. 2024 Feb 3;16(2):221. doi: 10.3390/pharmaceutics16020221

Table 8.

Regeneron Pharma Inc. (USA) patent portfolio and degree of technology and R&D concentration.

Target Technology (ADC Therapy) Corporate Patent Holdings
The number of patents in the last 20 years
(A)
The number of patents in the last 5 years
(B)
Degree of technology concentration in the last 20 years (%)
(C = A/E)
Degree of recent concentration in the last 5 years (%)
(D = B/A)
Total application number in the last 20 years
(E)
Application number in the last 5 years
(F)
Degree of R&D concentration in the last 5 years (%)
(G = F/E)
132 119 2.88 90.15 4576 2653 57.98